Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-24

FDA Approved: NITROFURANTOIN — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for nitrofurantoin (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (NITROFURANTOIN)